About MeI am an oncologist treating patients with blood cancers. I specialize in chronic lymphocytic leukemia (CLL) and b-cell lymphomas. I also serve as an associate professor in Ohio State’s division of hematology. Our approach to patient care is truly unique at OSUCCC – James. We work in teams of specialists, sub-specialists and super sub-specialists to better treat specific cancers, while never forgetting the power and value of personalized, patient-centered care. I was rated in the top 10 percent of physicians in the nation for patient satisfaction in 2017.
My research focus is on CLL and other blood cancers. I conduct laboratory research and lead clinical trials to develop novel therapies for patients with these conditions. I am especially interested in targeted therapies for patients with CLL and figuring out ways to overcome resistance to targeted therapies. Like my colleagues, I'm determined to keep searching until I find a cure.
In 2015, I was honored with a Young Physician-Scientist Award from the American Society of Clinical Investigation. My work has been featured in several medical publications, including the New England Journal of Medicine, Journal of Clinical Oncology, and Clinical Cancer Research. I have presented my research findings nationally and internationally.
At The James, we know there are no routine cancers. That's why I stay current with new knowledge in my field as a participant in several professional associations. I'm a member of the American Society of Clinical Oncology, American Association for Cancer Research and American Society of Hematology where I serve on a number of subcommittes. I also serve as a member of the Leukemia Committee and the Cancer in the Elderly Committee for the Alliance for Clinical Trials in Oncology, which is a group of cancer centers that designs and runs clinical trials to help improve the care of CLL patients around the country. By working with other specialists around the country, we can improve our understanding of CLL biology and therapy, and I can apply this knowledge to improve the lives of the patients we see here at the James.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2017
Specialties and conditions I treat
- Chronic Lymphocytic Leukemias
- Hairy Cell Leukemia
- Blood Cancers
Locations where I practice
Education and training
Ohio State University College of Medicine
Ohio State University Wexner Medical Center
7/1/2006 - 6/30/2008
More about my work
Ohio State University Wexner Medical Center
7/1/2009 - 6/30/2012
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Hematology)
American Board of Internal Medicine (Subspecialty: Medicine Oncology)
News about me
- Targeted Oral Therapy Combo Safe, Effective for Both Never-Treated and Relapsed Chronic Lymphocytic Leukemia
- Researchers Detail Reasons for Ibrutinib Therapy Discontinuation in Chronic Lymphocytic Leukemia
- Mechanisms of Ibrutinib Resistance Identified in Chronic Leukemia
- Ohio State Hematologist Recognized Nationally With Top 10 Clinical Research Achievement Award
- Ohio State Cancer Research Played a Significant Role in FDA Approval of Important New CLL Drug
- Older And Younger Chronic Leukemia Patients May Need Different Therapy
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/2017, Dr. Woyach has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Gerson Lehrman Group
- Gerson Lehrman Group, Inc
- Haymarket Medical Education
- Johnson & Johnson
- The American Society of Hematology